SANOFI (1SAN.MI) Stock Fundamental Analysis

BIT:1SAN • FR0000120578

82.18 EUR
+1.55 (+1.92%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Taking everything into account, 1SAN scores 5 out of 10 in our fundamental rating. 1SAN was compared to 49 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of 1SAN while its profitability can be described as average. 1SAN is not valued too expensively and it also shows a decent growth rate. Finally 1SAN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year 1SAN was profitable.
  • Each year in the past 5 years 1SAN has been profitable.
  • Each year in the past 5 years 1SAN had a positive operating cash flow.
1SAN.MI Yearly Net Income VS EBIT VS OCF VS FCF1SAN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • 1SAN has a better Return On Assets (10.63%) than 76.92% of its industry peers.
  • Looking at the Return On Equity, with a value of 18.84%, 1SAN is in the better half of the industry, outperforming 67.31% of the companies in the same industry.
  • The Return On Invested Capital of 1SAN (13.35%) is better than 65.38% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1SAN is significantly below the industry average of 13.98%.
  • The last Return On Invested Capital (13.35%) for 1SAN is above the 3 year average (7.41%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROIC 13.35%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
1SAN.MI Yearly ROA, ROE, ROIC1SAN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 20.63%, 1SAN belongs to the top of the industry, outperforming 80.77% of the companies in the same industry.
  • 1SAN's Profit Margin has declined in the last couple of years.
  • 1SAN's Operating Margin of 23.61% is in line compared to the rest of the industry. 1SAN outperforms 59.62% of its industry peers.
  • 1SAN's Operating Margin has improved in the last couple of years.
  • 1SAN has a Gross Margin (72.29%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of 1SAN has remained more or less at the same level.
Industry RankSector Rank
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
1SAN.MI Yearly Profit, Operating, Gross Margins1SAN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1SAN is still creating some value.
  • Compared to 1 year ago, 1SAN has less shares outstanding
  • Compared to 5 years ago, 1SAN has less shares outstanding
  • The debt/assets ratio for 1SAN is higher compared to a year ago.
1SAN.MI Yearly Shares Outstanding1SAN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
1SAN.MI Yearly Total Debt VS Total Assets1SAN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • 1SAN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • 1SAN has a better Debt to Equity ratio (0.18) than 80.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.68
WACC7.97%
1SAN.MI Yearly LT Debt VS Equity VS FCF1SAN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that 1SAN should not have too much problems paying its short term obligations.
  • 1SAN has a worse Current ratio (1.06) than 73.08% of its industry peers.
  • 1SAN has a Quick Ratio of 1.06. This is a bad value and indicates that 1SAN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1SAN's Quick ratio of 0.30 is on the low side compared to the rest of the industry. 1SAN is outperformed by 90.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.3
1SAN.MI Yearly Current Assets VS Current Liabilites1SAN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.82% over the past year.
  • 1SAN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.58% yearly.
  • 1SAN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.29%.
  • Measured over the past years, 1SAN shows a small growth in Revenue. The Revenue has been growing by 4.57% on average per year.
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.70% on average over the next years.
  • 1SAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.81% yearly.
EPS Next Y8.1%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
EPS Next 5Y7.7%
Revenue Next Year6.17%
Revenue Next 2Y6.28%
Revenue Next 3Y5.75%
Revenue Next 5Y4.81%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1SAN.MI Yearly Revenue VS Estimates1SAN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
1SAN.MI Yearly EPS VS Estimates1SAN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • 1SAN is valuated reasonably with a Price/Earnings ratio of 10.51.
  • Based on the Price/Earnings ratio, 1SAN is valued cheaper than 82.69% of the companies in the same industry.
  • 1SAN is valuated cheaply when we compare the Price/Earnings ratio to 27.07, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 9.72, the valuation of 1SAN can be described as reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1SAN indicates a rather cheap valuation: 1SAN is cheaper than 88.46% of the companies listed in the same industry.
  • 1SAN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.05.
Industry RankSector Rank
PE 10.51
Fwd PE 9.72
1SAN.MI Price Earnings VS Forward Price Earnings1SAN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1SAN.MI Per share data1SAN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of 1SAN may justify a higher PE ratio.
PEG (NY)1.3
PEG (5Y)1.88
EPS Next 2Y6.92%
EPS Next 3Y8.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • 1SAN has a Yearly Dividend Yield of 3.80%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.84, 1SAN pays a better dividend. On top of this 1SAN pays more dividend than 82.69% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, 1SAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.8%

5.2 History

  • The dividend of 1SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 34.36% of the earnings are spent on dividend by 1SAN. This is a low number and sustainable payout ratio.
  • 1SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.36%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
1SAN.MI Yearly Income VS Free CF VS Dividend1SAN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
1SAN.MI Dividend Payout.1SAN.MI Dividend Payout, showing the Payout Ratio.1SAN.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SANOFI

BIT:1SAN (2/27/2026, 7:00:00 PM)

82.18

+1.55 (+1.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap198.49B
Revenue(TTM)70.49B
Net Income(TTM)13.80B
Analysts77.33
Price Target98.32 (19.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.8%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)4
Avg Revenue beat(12)9.01%
Revenue beat(16)8
Avg Revenue beat(16)21.12%
PT rev (1m)-2.93%
PT rev (3m)-9.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.99%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.58%
Revenue NQ rev (1m)0.75%
Revenue NQ rev (3m)1.6%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.72%
Valuation
Industry RankSector Rank
PE 10.51
Fwd PE 9.72
P/S 2.97
P/FCF N/A
P/OCF N/A
P/B 2.71
P/tB 45.15
EV/EBITDA N/A
EPS(TTM)7.82
EY9.52%
EPS(NY)8.45
Fwd EY10.29%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.7
BVpS30.33
TBVpS1.82
PEG (NY)1.3
PEG (5Y)1.88
Graham Number73.06
Profitability
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROCE 16.17%
ROIC 13.35%
ROICexc 14.69%
ROICexgc 65.49%
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
FCFM N/A
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-ScoreN/A
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.3
Altman-Z N/A
F-ScoreN/A
WACC7.97%
ROIC/WACC1.68
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
EPS Next Y8.1%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
EPS Next 5Y7.7%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%
Revenue Next Year6.17%
Revenue Next 2Y6.28%
Revenue Next 3Y5.75%
Revenue Next 5Y4.81%
EBIT growth 1Y9.12%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year28.65%
EBIT Next 3Y14.49%
EBIT Next 5Y7.68%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI / 1SAN.MI FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 5 / 10 to 1SAN.MI.


What is the valuation status of SANOFI (1SAN.MI) stock?

ChartMill assigns a valuation rating of 5 / 10 to SANOFI (1SAN.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for SANOFI?

SANOFI (1SAN.MI) has a profitability rating of 6 / 10.


How financially healthy is SANOFI?

The financial health rating of SANOFI (1SAN.MI) is 3 / 10.


What is the expected EPS growth for SANOFI (1SAN.MI) stock?

The Earnings per Share (EPS) of SANOFI (1SAN.MI) is expected to grow by 8.1% in the next year.